TEAM - CENK CETIN

Cenk Cetin joined Hyku Biosciences in 2024 as Vice President and Head of Corporate Development. He has over 20 years of life sciences industry experience spanning business development, finance, company creation, and strategy. Before Hyku, Mr. Cetin was Head of BD Strategic Transactions at Evotec, a drug discovery and development company. Before joining Evotec, Mr. Cetin was with Novartis, Amgen, and Monsanto (a Bayer company), where he held positions with increasing responsibilities in business development and finance. He has an MBA from Maryville University in St. Louis and a B.S. in Business Administration from Bilkent University in Ankara, Türkiye.